The UK Cystic Fibrosis Gene Therapy Consortium
Welcome to the UK CFGTC website. Our aim is to develop gene therapy for Cystic Fibrosis (CF).
For more information on Cystic Fibrosis please click here.
We're pleased to say that recruitment for the Wave 1 Multi-Dose trial has now closed, and has achieved the target number of patients.
We are approximately halfway through, with 124 CF subjects being dosed in total; 15 of these have already completed the study, and two Data Safety Monitoring Board reviews have been passed without problems.
The final patients will receive their last dose during the summer of 2014 and unblinding of the results will take place thereafter.
"We would like to thank all those who have contacted us about participation, and everyone who has helped with recruitment; we really appreciate your efforts in making this trial a success."
If you have any general queries regarding the Clinical Trial then hopefully we can answer them here.
Information for Patients on Our Clinical Trial
Consortium Members' Internal Website
Medical Futures Innovation Award 2011